Tag

publications – access to medicines
June 1, 2021ByIn

Joint recommendations: The Health Technology Assessment 

ECL-Anticancer-Fund-policy-document_HTA-and-its-final-steps_13062021
Continue Reading
May 1, 2021ByIn

Civil society recommendations for improving the Orphan and Paediatric Regulations 

Joint_Recommendations_Paediatric_Orphan_Policy-dialogue_200521
Continue Reading
May 1, 2021ByIn

ECL’s contribution to the 2021 WHO Fair Pricing Forum 

2021-Fair-Pricing-Forum_ECL_contribution
Continue Reading
September 1, 2020ByIn

Support of Aspen Pharma commitments on excessive pricing  

ECL_Aspen-Commitments_comment-16092020
Continue Reading
September 1, 2020ByIn

Report: What is fair pricing?

ECL-What-is-a-Fair-Price-Paper_final
Continue Reading
August 1, 2020ByIn

Position paper: Europe’s Pharmaceutical Strategy 

ECL-Pharma-Strategy-Position-Paper-August-2020
Continue Reading
July 28, 2020ByIn

Public consultation: Intellectual Property Action Plan 

IP-Action-Plan_Roadmap-feedback_submitted-29-July-2020
Continue Reading
July 13, 2020ByIn

Public consultation: Pilot project ‘Market Launch of Intentions of Centrally Authorised Products’

Launch-Consultation_submitted-on-13-July-2020
Continue Reading
July 1, 2020ByIn

Joint recommendations: Towards fair prices of medicines in Europe 

AIM-Fair-Pricing-Principles_July2020
Continue Reading
June 24, 2020ByIn

Public consultation: The Pharmaceutical Strategy Roadmap 

EU-Pharma-Strategy-consultation_Roadmap-feedback-and-online-survey-comb-September-2020
Continue Reading
1 2 3 4 5